Medication Related-Problems and Associated Factors Among Patients with Hypertension at a Tertiary Care Hospital in Ethiopia: A Prospective Interventional Study

References

• Unger T, Borghi C, Charchar F., et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–1357. doi:10.1161/HYPERTENSIONAHA.120.15026
   PubMed Web of Science ®Google Scholar
• Kibret KT, Mesfin YM. Prevalence of hypertension in Ethiopia: a systematic meta-analysis. Public Health Rev. 2015;36(1):1–12. doi:10.1186/s40985-015-0014-z
   PubMedGoogle Scholar
• Amare F, Hagos B, Sisay M, Molla B. Uncontrolled hypertension in Ethiopia: a systematic review and meta-analysis of institution-based observational studies. BMC Cardiovasc Disord. 2020;20(1):1–9. doi:10.1186/s12872-020-01414-3
   PubMed Web of Science ®Google Scholar
• Schindler E, Richling I, Rose O. Pharmaceutical Care Network Europe (PCNE) drug-related problem classification version 9.00: German translation and validation. Int J Clin Pharm. 2021;43(3):726–730. doi:10.1007/s11096-020-01150-w
   PubMed Web of Science ®Google Scholar
• Srikanth A. Assessment of drug related problems and its associated factors among medical ward patients in University of Gondar teaching hospital, northwest Ethiopia: a prospective cross-sectional study. J Basic Clin Phar. 2017;5:8.
   Google Scholar
• Meknonnen GB, Biarra MK, Tekle MT, Bhagavathula AS. Assessment of drug related problems and its associated factors among medical ward patients in University of Gondar teaching hospital, northwest Ethiopia: a prospective cross-sectional study. J Basic Clin Pharma. 2017;8:16–21.
   Google Scholar
• Al-Azzam SI, Alzoubi KH, AbuRuz S, Alefan Q. Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan. Ther Clin Risk Manag. 2016;233–239. doi:10.2147/TCRM.S98165
   PubMed Web of Science ®Google Scholar
• Adem F, Abdela J, Edessa D, Hagos B, Nigussie A, Mohammed MA. Drug-related problems and associated factors in Ethiopia: a systematic review and meta-analysis. J Pharm Policy Pract. 2021;14(1):1–24. doi:10.1186/s40545-021-00312-z
   PubMedGoogle Scholar
• Georgiev KD, Hvarchanova N, Georgieva M, Kanazirev B. The role of the clinical pharmacist in the prevention of potential drug interactions in geriatric heart failure patients. Int J Clin Pharm. 2019;41(6):1555–1561. doi:10.1007/s11096-019-00918-z
   PubMed Web of Science ®Google Scholar
• Yates L, Valente M, Wadsworth C. Evaluation of pharmacist medication review service in an outpatient heart failure clinic. J Pharm Pract. 2020;33(6):820–826. doi:10.1177/0897190019842696
   PubMed Web of Science ®Google Scholar
• Guwatudde D, Nankya-Mutyoba J, Kalyesubula R, et al. The burden of hypertension in sub-Saharan Africa: a four-country cross sectional study. BMC Public Health. 2015;15(1):1–8. doi:10.1186/s12889-015-2546-z
   PubMed Web of Science ®Google Scholar
• Viktil KK, Blix HS. The impact of clinical pharmacists on drug‐related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102(3):275–280. doi:10.1111/j.1742-7843.2007.00206.x
   PubMed Web of Science ®Google Scholar
• Dixon-Woods M, Baker R, Charles K, et al. Culture and behaviour in the English national health service: overview of lessons from a large multimethod study. BMJ Qual Saf. 2014;23(2):106–115. doi:10.1136/bmjqs-2013-001947
   PubMed Web of Science ®Google Scholar
• Mannesse CK, Derkx F, De Ridder M, Man In’t Veld A, Van der Cammen T. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing. 2000;29(1):35–39. doi:10.1093/ageing/29.1.35
   PubMed Web of Science ®Google Scholar
• Salvi F, Marchetti A, D’Angelo F, Boemi M, Lattanzio F, Cherubini A. Adverse drug events as a cause of hospitalization in older adults. Drug Safety. 2012;35(1):29–45. doi:10.1007/BF03319101
   PubMedGoogle Scholar
• van den Bemt PM, Egberts TC, Brouwers JR, Brouwers JRBJ. Drug-related problems in hospitalised patients. Drug Safety. 2000;22(4):321–333. doi:10.2165/00002018-200022040-00005
   PubMed Web of Science ®Google Scholar
• Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41(2):192–199. doi:10.1016/s1086-5802(16)31229-3
   Google Scholar
• Al Hamid A, Aslanpour Z, Aljadhey H, Ghaleb M. Hospitalisation resulting from medicine-related problems in adult patients with cardiovascular diseases and diabetes in the United Kingdom and Saudi Arabia. Int J Environ Res Public Health. 2016;13(5):479. doi:10.3390/ijerph13050479
   PubMed Web of Science ®Google Scholar
• Seid E, Engidawork E, Alebachew M, Mekonnen D, Berha AB, Brunner-La Rocca H-P. Evaluation of drug therapy problems, medication adherence and treatment satisfaction among heart failure patients on follow-up at a tertiary care hospital in Ethiopia. PLoS One. 2020;15(8):e0237781. doi:10.1371/journal.pone.0237781
   PubMed Web of Science ®Google Scholar
• Niriayo YL, Kumela K, Kassa TD, Angamo MT, Frey R. Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University specialized hospital, Southwest Ethiopia. PLoS One. 2018;13(10):e0206120. doi:10.1371/journal.pone.0206120
   PubMed Web of Science ®Google Scholar
• Tsianou K, Giannakeas N, Tsipouras M, et al. Accessing patient views about medication in chronic conditions using the Beliefs about Medicine Questionnaire (BMQ): a review study. J Drug Res Dev. 2017;3(2):1–9.
   Google Scholar
• Tox L. Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): national institute of diabetes and digestive and kidney diseases; 2012.
   Google Scholar
• Yusuff KB, Tayo F. Frequency, types and severity of medication use-related problems among medical outpatients in Nigeria. Int J Clin Pharm. 2011;33(3):558. doi:10.1007/s11096-011-9508-z
   PubMed Web of Science ®Google Scholar
• Celin A, Seuma J, Ramesh A. Assessment of drug related problems in stroke patients admitted to a South Indian tertiary care teaching hospital. Indian J Pharm Pract. 2012;5(4):28–33.
   Google Scholar
• Acheampong F, Nkansah FA, Anto BP. Drug-related problems and their clinical interventions in a Ghanaian teaching hospital. Safety in Health. 2016;2(1):1–7. doi:10.1186/s40886-016-0050-5
   Google Scholar
• Rohilla A, Yadav S. Adverse drug reactions: an overview. Int J Pharmacol Res. 2013;3(1):10–12.
   Google Scholar
• Beezer J, Al Hatrushi M, Kurdi A, Forsyth P. Polypharmacy definition and prevalence in heart failure: a systematic review. Heart Fail Rev. 2021;2021:1–28.
   Google Scholar
• Shareef J, Sandeep B, Shastry C. Assessment of drug related problems in patients with cardiovascular diseases in a tertiary care teaching hospital. J Pharm Care. 2014;2012:70–76.
   Google Scholar
• Biradar SM, Indu P, Kalyane N, et al. Impact of drug-related problems and clinical pharmacist interventions on therapeutic outcomes of the patients admitted to a tertiary care hospital. Int J Med Sci Public Health. 2017;6(5):867–873. doi:10.5455/ijmsph.2017.1164412122016
   Google Scholar
• Abdela OA, Bhagavathula AS, Getachew H, Kelifa Y. Risk factors for developing drug-related problems in patients with cardiovascular diseases attending Gondar University Hospital, Ethiopia. J Pharm Bioallied Sci. 2016;8(4):289. doi:10.4103/0975-7406.199335
   PubMedGoogle Scholar
• Gastelurrutia P, Benrimoj SI, Espejo J, Tuneu L, Mangues MA, Bayes-Genis A. Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a multidisciplinary HF clinic. J Card Fail. 2011;17(3):217–223. doi:10.1016/j.cardfail.2010.10.009
   PubMed Web of Science ®Google Scholar
• Dempsey JT, Matta LS, Carter DM, et al. Assessment of drug therapy-related issues in an outpatient heart failure population and the potential impact of pharmacist-driven intervention. J Pharm Pract. 2017;30(3):318–323. doi:10.1177/0897190016641491
   PubMedGoogle Scholar
• van Der Wal MH, Jaarsma T, Moser DK, Veeger NJ, van Gilst WH, van Veldhuisen DJ. Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J. 2006;27(4):434–440. doi:10.1093/eurheartj/ehi603
   PubMed Web of Science ®Google Scholar
• Gelchu T, Abdela J. Drug therapy problems among patients with cardiovascular disease admitted to the medical ward and had a follow-up at the ambulatory clinic of Hiwot fana specialized university hospital: the case of a tertiary hospital in eastern Ethiopia. SAGE Open Med. 2019;7:2050312119860401. doi:10.1177/2050312119860401
   Web of Science ®Google Scholar
• Gona OJ, Shambu SK, Madhan R. Frequency and nature of drug‐related problems in patients with acute coronary syndrome: role of the clinical pharmacist in coronary care practice. J Pharm Pract Res. 2021;51(1):36–42. doi:10.1002/jppr.1684
   Google Scholar
• Hailu BY, Berhe DF, Gudina EK, Gidey K, Getachew M. Drug related problems in admitted geriatric patients: the impact of clinical pharmacist interventions. BMC Geriatr. 2020;20(1):1–8. doi:10.1186/s12877-020-1413-7
   Web of Science ®Google Scholar
• Hsu W-T, Shen L-J, Lee C-M. Drug-related problems vary with medication category and treatment duration in Taiwanese heart failure outpatients receiving case management. J Formo Med Assoc. 2016;115(5):335–342. doi:10.1016/j.jfma.2015.11.014
   PubMed Web of Science ®Google Scholar
• Wendie TF, Angamo MT. Drug-therapy problems and predictors among hospitalized heart-failure patients: a prospective observational study. Drug Healthc Patient Saf. 2020;12:281. doi:10.2147/DHPS.S268923
   PubMed Web of Science ®Google Scholar
• Murtaza G, Khan MYG, Azhar S, Khan SA, Khan TM. Assessment of potential drug–drug interactions and its associated factors in the hospitalized cardiac patients. Saudi Pharm J. 2016;24(2):220–225. doi:10.1016/j.jsps.2015.03.009
   PubMed Web of Science ®Google Scholar
• Sharma S, Chhetri HP, Alam K. A study of potential drug-drug interactions among hospitalized cardiac patients in a teaching hospital in Western Nepal. Indian J Pharmacol. 2014;46(2):152. doi:10.4103/0253-7613.129303
   PubMed Web of Science ®Google Scholar
• Wright S, Verouhis D, Gamble G, Swedberg K, Sharpe N, Doughty R. Factors influencing the length of hospital stay of patients with heart failure. Eur J Heart Fail. 2003;5(2):201–209. doi:10.1016/S1388-9842(02)00201-5
   PubMed Web of Science ®Google Scholar
• Urbina O, Ferrández O, Luque S, et al. Patient risk factors for developing a drug-related problem in a cardiology ward. Ther Clin Risk Manag. 2015;11:9. doi:10.2147/TCRM.S71749
   PubMed Web of Science ®Google Scholar
• Sewagegn N, Fekadu S, Chanie T. Adherence to self-care behaviours and knowledge on treatment among heart failure patients in Ethiopia: the case of a tertiary teaching hospital. J Pharm Care Health Sys. 2015;10:2376–2419.
   Google Scholar
• Mateti U, Rajakannan T, Nekkanti H, Rajesh V, Mallaysamy S, Ramachandran P. Drug-drug interactions in hospitalized cardiac patients. J Young Pharm. 2011;3(4):329–333. doi:10.4103/0975-1483.90246
   PubMedGoogle Scholar
• Mohammed S, Poudel S, Laloo F, Madhur A, Robert R, Mathew B. Assessment of drug-related problems in a tertiary care teaching hospital, India. Asian J Pharm Clin Res. 2017;10(2):310–313. doi:10.22159/ajpcr.2017.v10i2.15678
   Google Scholar
• Garedow AW, Mulisa Bobasa E, Desalegn Wolide A, et al. Drug-related problems and associated factors among patients admitted with chronic kidney Disease at Jimma University Medical Center, Jimma Zone, Jimma, Southwest Ethiopia: a hospital-based prospective observational study. Int J Nephrol. 2019;2019:1–9. doi:10.1155/2019/1504371
   Web of Science ®Google Scholar
• Tigabu BM, Daba D, Habte B. Drug-related problems among medical ward patients in Jimma university specialized hospital, Southwest Ethiopia. J Res Pharm Pract. 2014;3(1):1. doi:10.4103/2279-042X.132702
   PubMedGoogle Scholar
• Babelghaith SD, Wajid S, Alrabiah Z, et al. Drug-related problems and pharmacist intervention at a general hospital in the Jazan Region, Saudi Arabia. Risk Manag Healthc Policy. 2020;13:373. doi:10.2147/RMHP.S247686
   PubMed Web of Science ®Google Scholar
• Gökçekuş L, Mestrovic A, Basgut B. Pharmacist intervention in drug-related problems for patients with cardiovascular diseases in selected community pharmacies in Northern Cyprus. Trop J Pharm Res. 2016;15(10):2275–2281. doi:10.4314/tjpr.v15i10.29
   Web of Science ®Google Scholar